According to a new report published by Introspective Market Research, Lactose Market by Type, Application, and Form, The Global Lactose Market Size Was Valued at USD 1.81 Billion in 2023 and is Projected to Reach USD 10.71 Billion by 2032, Growing at a CAGR of 21.84%.

Market Overview

The Lactose Market encompasses the production and commercialization of lactose derived primarily from whey, a by-product of cheese manufacturing. Lactose is widely used across food & beverage, pharmaceutical, and infant nutrition industries due to its functional properties, including mild sweetness, solubility, stability, and cost-effectiveness. It serves as a key excipient in pharmaceutical tablets and capsules and as an essential carbohydrate source in infant formula.

Growth Driver

One of the key growth drivers of the Lactose Market is the rapid expansion of the pharmaceutical industry globally. Lactose is extensively used as a filler and binder in tablet and capsule formulations due to its excellent compressibility and stability. Increasing prevalence of chronic diseases, growing generic drug production, and expanding healthcare infrastructure in emerging economies are driving higher demand for pharmaceutical excipients. Furthermore, the rising production of infant nutrition products, especially in Asia-Pacific and Europe, is significantly contributing to lactose consumption, thereby accelerating overall market growth during the forecast period.

Market Opportunity

A major market opportunity lies in the increasing demand for high-purity and specialty lactose variants used in advanced pharmaceutical and nutraceutical formulations. As biologics, inhalation drugs, and precision medicines gain traction, the need for ultra-refined lactose grades is expanding. Additionally, technological advancements in dairy processing and whey valorization are enabling manufacturers to produce value-added lactose derivatives. Emerging markets with growing dairy processing industries and supportive government policies also present strong investment opportunities for lactose producers seeking capacity expansion and global market penetration.

Lactose Market, Segmentation

Type

The Type segment is further classified into Monohydrate Lactose, Anhydrous Lactose, and Galactose. Among these, the Monohydrate Lactose sub-segment accounted for the highest market share in 2023. Monohydrate lactose is widely used in pharmaceutical tablet formulations due to its excellent binding properties and cost efficiency. It provides consistent particle size and stability, which are essential for uniform drug manufacturing. Additionally, its broad availability and compatibility with a wide range of active pharmaceutical ingredients (APIs) make it the preferred choice among drug manufacturers globally.

Application

The Application segment is further classified into Food & Beverage, Pharmaceuticals, Infant Formula, and Animal Feed. Among these, the Pharmaceuticals sub-segment accounted for the highest market share in 2023. Lactose is extensively used as a carrier in dry powder inhalers and as a filler in oral solid dosage forms. The increasing global demand for generic medicines, rising R&D investments, and expansion of pharmaceutical manufacturing facilities are significantly boosting demand within this segment, strengthening its dominance in the global lactose market.

Some of The Leading/Active Market Players Are-

• Fonterra Co-operative Group Limited (New Zealand)
  • Arla Foods Ingredients Group P/S (Denmark)
  • Lactalis Ingredients (France)
  • Kerry Group plc (Ireland)
  • FrieslandCampina Ingredients (Netherlands)
  • Glanbia plc (Ireland)
  • Hilmar Cheese Company, Inc. (USA)
  • Armor Proteines (France)
  • MEGGLE GmbH & Co. KG (Germany)
  • MILEI GmbH (Germany)
  • Saputo Inc. (Canada)
  • Agropur Cooperative (Canada)

and other active players.

Key Industry Developments

News 1:
In February 2024, a leading dairy ingredient manufacturer announced expansion of its pharmaceutical-grade lactose production capacity to meet rising global demand.
The expansion focuses on enhancing production efficiency and meeting stringent quality standards required for inhalation and biologics applications. This move strengthens the company’s position in the high-growth pharmaceutical excipient segment.

News 2:
In November 2023, a European dairy processor introduced a new high-purity lactose variant targeted at infant nutrition manufacturers.
The product launch aims to support growing demand for premium infant formula products, particularly in Asia-Pacific markets. The innovation emphasizes improved solubility and enhanced safety standards for specialized nutrition applications.

Key Findings of the Study

• Monohydrate Lactose dominated the Type segment in 2023
  • Pharmaceuticals accounted for the largest application share
  • Rapid pharmaceutical expansion drives market growth
  • High-purity lactose demand is a major emerging trend
  • Europe and Asia-Pacific lead global production